Tracking weak global cues, the benchmark indices ended in the negative territory on Wednesday; although they recovered from the intraday low amid buying in Reliance Industries (RIL), Bharti Airtel, and Tata Steel. News that AstraZeneca Pharma has "voluntarily paused" a randomized clinical trial of its coronavirus vaccine after a volunteer developed an unexplained illness, weighed on the investor sentiment.
The S&P BSE Sensex slid 171 points, or 0.45 per cent to settle at 39,194 while the NSE's Nifty50 index ended at 11,278 levels, down 39 points, or 0.35 per cent. India VIX dropped nearly 3 per cent to 22.05 levels.
SBI (down

)